|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 2305263 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10178116.9 |
| Date of filing the European patent application | 2007-06-07 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation | 2012-10-25 |
| (30) | Number | Date | Country code |
| 07109816 | 2007-06-07 | EP |
| (72) |
Goncalves, Elisabete, CH
Kalb, Oskar, CH
Mutz, Michael, DE
Wirth, Wolfgang, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Stabilizuotos amorfinės imatinibo mezilato formos |
| Stabilized amorphous forms of imatinib mesylate |
| Payment date | Validity (years) | Amount | |
| 2015-05-25 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-06-07 |